{"nct_id":"NCT03515837","title":"Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2018-06-29","start_date_type":"ACTUAL","primary_completion_date":"2023-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}